Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals

Written By John Flores

Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals. Click here for the full article.

Broce S, Hensley L, Sato T, Lehrer-Graiwer J, Essrich C, Edwards KJ, Pajda J, Davis CJ, Bhadresh R, Hurt CR, Freeman B, Lingappa VR, Kelleher CA, Karpuj MV. Biochemical and biophysical characterization of cell-free synthesized Rift Valley fever virus nucleoprotein capsids enables in vitro screening to identify novel antivirals. Biol Direct. 2016 May 14;11:25. doi: 10.1186/s13062-016-0126-5. PMID: 27179769; PMCID: PMC4867995.

John Flores https://boxc.ar
Previous

Divergent effects of Porcupine and Wntless on WNT1 trafficking, secretion, and signaling
Next

Host–rabies virus protein–protein interactions as druggable antiviral targets